Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 254

1.

Primary cutaneous ALCL with phosphorylated/activated cytoplasmic ALK and novel phenotype: EMA/MUC1+, cutaneous lymphocyte antigen negative.

Kadin ME, Pinkus JL, Pinkus GS, Duran IH, Fuller CE, Onciu M, Kawaguchi H, Morris SW.

Am J Surg Pathol. 2008 Sep;32(9):1421-6. doi: 10.1097/PAS.0b013e3181648d6d.

PMID:
18670345
2.

The t(2;5) in human lymphomas.

Kadin ME, Morris SW.

Leuk Lymphoma. 1998 Apr;29(3-4):249-56. Review.

PMID:
9684923
3.

Lymphohistiocytic anaplastic large cell lymphoma involving skin: a diagnostic challenge.

Chuang SS, Hsieh YC, Ye H, Hwang WS.

Pathol Res Pract. 2009;205(4):283-7. doi: 10.1016/j.prp.2008.10.009. Epub 2008 Dec 16.

PMID:
19091487
4.
5.

Morphological and phenotypic features in pediatric large cell lymphoma and their correlation with ALK expression and the t(2;5)(p23;q35) translocation.

Sherman CG, Zielenska M, Lorenzana AN, Pulford KA, Mason DY, Hutchison RE, Thorner PS.

Pediatr Dev Pathol. 2001 Mar-Apr;4(2):129-37.

PMID:
11178628
8.

Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis.

Sarris AH, Luthra R, Papadimitracopoulou V, Waasdorp M, Dimopoulos MA, McBride JA, Cabanillas F, Duvic M, Deisseroth A, Morris SW, Pugh WC.

Blood. 1996 Sep 1;88(5):1771-9.

9.

ALK-negative systemic anaplastic large cell lymphoma: differential diagnostic and prognostic aspects--a review.

ten Berge RL, Oudejans JJ, Ossenkoppele GJ, Meijer CJ.

J Pathol. 2003 May;200(1):4-15. Review.

PMID:
12692835
10.

A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation.

Lamant L, Dastugue N, Pulford K, Delsol G, Mariamé B.

Blood. 1999 May 1;93(9):3088-95.

11.

Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas.

Salaverria I, Beà S, Lopez-Guillermo A, Lespinet V, Pinyol M, Burkhardt B, Lamant L, Zettl A, Horsman D, Gascoyne R, Ott G, Siebert R, Delsol G, Campo E.

Br J Haematol. 2008 Mar;140(5):516-26. doi: 10.1111/j.1365-2141.2007.06924.x.

PMID:
18275429
12.

CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features.

Stein H, Foss HD, Dürkop H, Marafioti T, Delsol G, Pulford K, Pileri S, Falini B.

Blood. 2000 Dec 1;96(12):3681-95. Review.

13.

Chromosomal abnormalities in nodal and extranodal CD30+ anaplastic large cell lymphomas: infrequent detection of the t(2;5) in extranodal lymphomas.

Ott G, Katzenberger T, Siebert R, DeCoteau JF, Fletcher JA, Knoll JH, Kalla J, Rosenwald A, Ott MM, Weber-Matthiesen K, Kadin ME, Müller-Hermelink HK.

Genes Chromosomes Cancer. 1998 Jun;22(2):114-21.

PMID:
9598798
14.

Detection of a subset of CD30+ anaplastic large cell lymphoma by interphase fluorescence in situ hybridization.

Shin HJ, Thorson P, Gu J, Katz RL.

Diagn Cytopathol. 2003 Aug;29(2):61-6.

PMID:
12889041
15.

Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma.

Eckerle S, Brune V, Döring C, Tiacci E, Bohle V, Sundström C, Kodet R, Paulli M, Falini B, Klapper W, Chaubert AB, Willenbrock K, Metzler D, Bräuninger A, Küppers R, Hansmann ML.

Leukemia. 2009 Nov;23(11):2129-38. doi: 10.1038/leu.2009.161. Epub 2009 Aug 6.

PMID:
19657361
16.

Molecular characterization of the t(2;5) (p23; q35) translocation in anaplastic large cell lymphoma (Ki-1) and Hodgkin's disease.

Yee HT, Ponzoni M, Merson A, Goldstein M, Scarpa A, Chilosi M, Menestrina F, Pittaluga S, de Wolf-Peeters C, Shiota M, Mori S, Frizzera G, Inghirami G.

Blood. 1996 Feb 1;87(3):1081-8.

17.

[Clinicopathologic features of 66 cases of anaplastic lymphoma kinase positive and negative systemic anaplastic large cell lymphoma: a comparative study].

Shi Y, Chen G, Zhou XG, Gong LP, Yu R, Zheng YY, Xie JL, Jin Y.

Zhonghua Bing Li Xue Za Zhi. 2010 Apr;39(4):235-9. Chinese.

PMID:
20654121
18.

ALK-positive (2p23 rearranged) anaplastic large cell lymphoma with localization to the skin in a pediatric patient.

Pulitzer M, Ogunrinade O, Lin O, Steinherz P.

J Cutan Pathol. 2015 Mar;42(3):182-7. doi: 10.1111/cup.12446. Epub 2015 Feb 5.

19.

ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project.

Savage KJ, Harris NL, Vose JM, Ullrich F, Jaffe ES, Connors JM, Rimsza L, Pileri SA, Chhanabhai M, Gascoyne RD, Armitage JO, Weisenburger DD; International Peripheral T-Cell Lymphoma Project.

Blood. 2008 Jun 15;111(12):5496-504. doi: 10.1182/blood-2008-01-134270. Epub 2008 Apr 2.

20.

The cryptic inv(2)(p23q35) defines a new molecular genetic subtype of ALK-positive anaplastic large-cell lymphoma.

Wlodarska I, De Wolf-Peeters C, Falini B, Verhoef G, Morris SW, Hagemeijer A, Van den Berghe H.

Blood. 1998 Oct 15;92(8):2688-95.

Supplemental Content

Support Center